Font Size:
Site Colors:
S - Skip navigation
1 - Home page
4 - Search
Accessibility Statement

From The Director

Applying one’s experience, skills, and efforts to accumulate and implement life-promoting knowledge is most likely one of the most uplifting endeavors. This challenging year of the COVID-19 pandemic acutely demonstrated that conducting biomedical research is one of the most important endeavors whether it is addressing a new question or translating its answer into therapy. I feel tremendous pride to be the director of an organization that has the health and wellbeing of humankind as its driving vision.

The Rappaport Institute for Biomedical Research is an exemplary realization of such vision. Over the years, thanks to the dedicated contributions of Ruth and Bruce Rappaport, now succeeded by the ceaseless generosity of their family, the Rappaport Institute at the Technion’s Faculty of Medicine has become a shining example of biomedical excellence. For decades, it has been shaping clinical practices by introducing fundamental life-science discoveries and approaches, leading to the development of new therapies. As many before me have attested, today’s biomedical research is tomorrow’s medical practice, and the work at the Rappaport Institute confirms this. I feel honored to have the opportunity to further advance this excellent institute. Our world’s biomedical and biotechnological demands are constantly shifting and expanding, and I see the Rappaport Institute spearheading the paths to solutions for these challenges.

Eyal Gottlieb_20201222171644.266.jpg

Prof. Eyal Gottlieb

Director, Rappaport Institute for Biomedical Research
The Ruth and Bruce Rappaport Faculty of Medicine
Technion – Israel Institute of Technology
Haifa, Israel

Confirm and pay